Molecular characterization and antimicrobial susceptibility testing of Escherichia coli isolates from patients with urinary tract infections in 20 Chinese Hospitals

Journal of Clinical Microbiology

Volumn 49, Issue 7, 2011, Pages 2496-2501

  Cao, Xiaoli ^a   Cavaco, Lina M ^b   Lv, Yuan ^a   Li, Yun ^a   Zheng, Bo ^a   Wang, Pengyuan ^a   Hasman, Henrik ^b   Liu, Yucun ^a   Aarestrup, Frank M ^b  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE AMPC; CEFAZOLIN; CEFEPIME; CEFOPERAZONE; CEFPODOXIME; CEFPROZIL; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CEPHALOSPORINASE; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; EXTENDED SPECTRUM CEPHALOSPORINASE; GENTAMICIN; IMIPENEM; LATAMOXEF; LEVOFLOXACIN; MOXIFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

AAC(6') IB CR GENE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BLACTX M 14 GENE; BLACTX M 15 GENE; BLACTX M GENE; CHINA; ESCHERICHIA COLI; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PHYLOGENY; PLASMID; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; QEPA GENE; QNRS1 GENE; TERTIARY HEALTH CARE; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CHINA; CLUSTER ANALYSIS; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENETIC VARIATION; GENOTYPE; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; PLASMIDS; POLYMERASE CHAIN REACTION; URINARY TRACT INFECTIONS;

ESCHERICHIA COLI;

EID: 79959843990     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02503-10     Document Type: Article

References (47)

1. Batchelor, M., et al. 2008. Development of a miniaturised microarray-based assay for the rapid identification of antimicrobial resistance genes in Gram-negative bacteria. Int. J. Antimicrob. Agents 31:440-451.
2. Bayraktar, B., B. Toksoy, and E. Bulut. 2010. Detection of bla(CTX-M) β-lactamase genes in extended-spectrum β-lactamase producing gram-negative bacteria. Mikrobiyol. Bul. 44:187-196.
3. Carattoli, A. 2009. Resistance plasmid families in Enterobacteriaceae. Antimicrob. Agents Chemother. 53:2227-2238.
4. Carattoli, A., et al. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219-228. (Pubitemid 41597366)
5. Carlos, C., et al. 2010. Escherichia coli phylogenetic group determination and its application in the identification of the major animal source of fecal contamination. BMC Microbiol. 10:161.
6. Caroff, N., E. Espaze, I. Berard, H. Richet, and A. Reynaud. 1999. Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum β-lactamase production. FEMS Microbiol. Lett. 173:459-465.
7. Caroff, N., E. Espaze, D. Gautreau, H. Richet, and A. Reynaud. 2000. Analysis of the effects of -42 and -32 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing ampC. J. Antimicrob. Chemother. 45:783-788. (Pubitemid 30348947)
8. Cavaco, L. M., et al. 2008. Prevalence of quinolone resistance mechanisms and associations to minimum inhibitory concentrations in quinolone-resistant Escherichia coli isolated from humans and swine in Denmark. Microb. Drug Resist. 14:163-169.
9. Cavaco, L. M., H. Hasman, S. Xia, and F. M. Aarestrup. 2009. qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob. Agents Chemother. 53:603-608.
10. Clermont, O., S. Bonacorsi, and E. Bingen. 2000. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66:4555-4558.
11. Clinical Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. M100-S20. CLSI, Wayne, PA.
12. Coque, T. M., et al. 2008. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg. Infect. Dis. 14:195-200.
13. Gordon, D. M., O. Clermont, H. Tolley, and E. Denamur. 2008. Assigning Escherichia coli strains to phylogenetic groups: multi-locus sequence typing versus the PCR triplex method. Environ. Microbiol. 10:2484-2496.
14. Hasman, H., D. Mevius, K. Veldman, I. Olesen, and F. M. Aarestrup. 2005. β-Lactamases among extended-spectrum β-lactamase (ESBL)-resistant Salmonella from poultry, poultry products and human patients in The Netherlands. J. Antimicrob. Chemother. 56:115-121.
15. Ho, P. L., et al. 2007. Community emergence of CTX-M type extended-spectrum β-lactamases among urinary Escherichia coli from women. J. Antimicrob. Chemother. 60:140-144. (Pubitemid 47073288)
16. Hopkins, K. L., et al. 2006. Replicon typing of plasmids carrying CTX-M or CMY β-lactamases circulating among Salmonella and Escherichia coli isolates. Antimicrob. Agents Chemother. 50:3203-3206. (Pubitemid 44396441)
17. Jacoby, G. A. 2009. AmpC β-lactamases. Clin. Microbiol. Rev. 22:161-182.
18. Jakobsen, L., A. M. Hammerum, and N. Frimodt-Moller. 2010. Detection of clonal group A Escherichia coli isolates from broiler chickens, broiler chicken meat, community-dwelling humans, and urinary tract infection (UTI) patients and their virulence in a mouse UTI model. Appl. Environ. Microbiol. 76:8281-8284.
19. Jakobsen, L., et al. 2010. Escherichia coli isolates from broiler chicken meat, broiler chickens, pork, and pigs share phylogroups and antimicrobial resistance with community-dwelling humans and patients with urinary tract infection. Foodborne Pathog. Dis. 7:537-547.
20. Johnson, J. R., B. Johnston, C. Clabots, M. A. Kuskowski, and M. Castanheira. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. 51:286-294.
21. Jones, R. N., K. C. Kugler, M. A. Pfaller, and P. L. Winokur. 1999. Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997. Diagn. Microbiol. Infect. Dis. 35:55-63.
22. Li, B., et al. 2011. High prevalence of CTX-M β-lactamases in faecal Escherichia coli strains from healthy humans in Fuzhou, China. Scand. J. Infect. Dis. 43:170-174.
23. Li, J., et al. 2010. Dissemination of cefotaxime-M-producing Escherichia coli isolates in poultry farms, but not swine farms, in China. Foodborne Pathog. Dis. 7:1387-1392.
24. Li, L., et al. 2010. Characterization of antimicrobial resistance and molecular determinants of β-lactamase in Escherichia coli isolated from chickens in China during 1970-2007. Vet. Microbiol. 144:505-510.
25. Liu, J. H., et al. 2007. Detection and characterisation of CTX-M and CMY 2 β-lactamases among Escherichia coli isolates from farm animals in Guangdong Province of China. Int. J. Antimicrob. Agents 29:576-581.
26. Lopez-Cerero, L., et al. 2011. Characterisation of clinical and food animal Escherichia coli isolates producing CTX-M-15 extended-spectrum β-lactamase belonging to ST410 phylogroup A. Int. J. Antimicrob. Agents 37:365-367.
27. Ma, L., H. Matsuo, Y. Ishii, and K. Yamaguchi. 2002. Characterization of cefotaxime-resistant Escherichia coli isolates from a nosocomial outbreak at three geriatric hospitals. J. Infect. Chemother. 8:155-162.
28. Marcade, G., et al. 2009. Replicon typing of plasmids in Escherichia coli producing extended-spectrum β-lactamases. J. Antimicrob. Chemother. 63:67-71.
29. Mshana, S. E., et al. 2009. Conjugative IncFI plasmids carrying CTX-M-15 among Escherichia coli ESBL producing isolates at a university hospital in Germany. BMC Infect. Dis. 9:97.
30. Novais, A., et al. 2007. Emergence and dissemination of Enterobacteriaceae isolates producing CTX-M-1-like enzymes in Spain are associated with IncFII (CTX-M-15) and broad-host-range (CTX-M-1, -3, and -32) plasmids. Antimicrob. Agents Chemother. 51:796-799.
31. Park, S. D., et al. 2010. Prevalence and resistance patterns of extended-spectrum and AmpC β-lactamase in Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Salmonella serovar Stanley in a Korean tertiary hospital. APMIS 118:801-808.
32. Peirano, G., et al. 2010. High prevalence of ST131 isolates producing CTX-M- 15 and CTX-M-14 among extended-spectrum-β-lactamase-producing Escherichia coli isolates from Canada. Antimicrob. Agents Chemother. 54:1327-1330.
33. Perichon, B., P. Courvalin, and M. Galimand. 2007. Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli. Antimicrob. Agents Chemother. 51:2464-2469. (Pubitemid 47047325)
34. Regua-Mangia, A. H., et al. 2010. Molecular characterization of uropathogenic and diarrheagenic Escherichia coli pathotypes. J. Basic Microbiol. 50(Suppl. 1):S107-S115.
35. Ribot, E. M., et al. 2006. Standardization of pulsed-field gel electrophoresis protocols for the subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathog. Dis. 3:59-67.
36. Ruiz, J. 2003. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J. Antimicrob. Chemother. 51:1109-1117.
37. Sidjabat, H. E., et al. 2009. Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania. Antimicrob. Agents Chemother. 53:4733-4739.
38. Sirichote, P., et al. 2010. Molecular characterization of extended-spectrum cephalosporinase-producing Salmonella enterica serovar Choleraesuis isolates from patients in Thailand and Denmark. J. Clin. Microbiol. 48:883-888.
39. Tian, G. B., et al. 2009. Detection of CTX-M-15, CTX-M-22, and SHV-2 extended-spectrum β-lactamases (ESBLs) in Escherichia coli fecal-sample isolates from pig farms in China. Foodborne Pathog. Dis. 6:297-304.
40. Tian, S. F., C. B. Y. Z. Chu, and S. Wang. 2008. Prevalence of rectal carriage of extended-spectrum β-lactamase-producing Escherichia coli among elderly people in community settings in China. Can. J. Microbiol. 54:781-785.
41. Tracz, D. M., et al. 2007. ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates. FEMS Microbiol. Lett. 270:265-271.
42. Valverde, A., et al. 2009. Spread of bla(CTX-M-14) is driven mainly by IncK plasmids disseminated among Escherichia coli phylogroups A, B1, and D in Spain. Antimicrob. Agents Chemother. 53:5204-5212.
43. Veldman, K., et al. 2011. International collaborative study on the occurrence of plasmid-mediated quinolone resistance in Salmonella enterica and Escherichia coli isolated from animals, humans, food and the environment in 13 European countries. J. Antimicrob. Chemother. 66:1278-1286.
44. Wang, M., et al. 2009. New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis. Antimicrob. Agents Chemother. 53:1892-1897.
45. Yu, W., L. Bing, and L. Zhenhua. 2009. AmpC promoter and attenuator mutations affect function of three Escherichia coli strains. Curr. Microbiol. 59:244-247.
46. Yu, Y., et al. 2007. Resistance of strains producing extended-spectrum β-lactamases and genotype distribution in China. J. Infect. 54:53-57. (Pubitemid 44932943)
47. Zhanel, G. G., et al. 2000. A Canadian national surveillance study of urinary tract isolates from outpatients: comparison of the activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin, and ciprofloxacin. The Canadian Urinary Isolate Study Group. Antimicrob. Agents Chemother. 44:1089-1092.